The Role and Mechanism of Lysine Methyltransferase and Arginine Methyltransferase in Kidney Diseases

Methylation can occur in both histones and non-histones. Key lysine and arginine methyltransferases under investigation for renal disease treatment include enhancer of zeste homolog 2 (EZH2), G9a, disruptor of telomeric silencing 1-like protein (DOT1L), and protein arginine methyltransferases (PRMT)...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Xun Zhou, Hui Chen, Jinqing Li, Yingfeng Shi, Shougang Zhuang, Na Liu
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Frontiers Media S.A. 2022-04-01
Edice:	Frontiers in Pharmacology
Témata:	epigenetic modification lysine methyltransferase arginine methyltransferase acute kidney injury chronic kidney diseases renal cell carcinoma
On-line přístup:	https://www.frontiersin.org/articles/10.3389/fphar.2022.885527/full
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!